On-target, off-tumor toxicity refers to the adverse effects that occur when a therapeutic agent, such as a targeted cancer therapy, accurately binds to its intended molecular target but also affects normal cells that express the same target. This phenomenon can lead to significant side effects, complicating cancer treatment and impacting patient quality of life.
